Yu Fan
Latest statistics and disclosures from Yu Fan's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABGI, AVIR, AGLE, DFFN, and represent 100.00% of Yu Fan's stock portfolio.
- Reduced shares in these 2 stocks: LUNG (-$14M), AVIR.
- Sold out of its positions in LUNG.
- Yu Fan was a net seller of stock by $-17M.
- Yu Fan has $8.8M in assets under management (AUM), dropping by -76.90%.
- Central Index Key (CIK): 0001668029
Tip: Access up to 7 years of quarterly data
Positions held by Yu Fan consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Yu Fan
Companies in the Yu Fan portfolio as of the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Abg Acquisition Corp I Cl A Shs (ABGI) | 55.5 | $4.9M | 501k | 9.80 | ||
| Atea Pharmaceuticals (AVIR) | 34.9 | $3.1M | -52% | 144k | 21.48 | |
| Aeglea Biotherapeutics (AGLE) | 8.8 | $780k | 112k | 6.96 | ||
| Diffusion Pharmaceuticals In Com Par (DFFN) | 0.7 | $66k | 90k | 0.73 |
Past Filings by Yu Fan
SEC 13F filings are viewable for Yu Fan going back to 2020
- Yu Fan 2021 Q1 restated filed Sept. 17, 2021
- Yu Fan 2021 Q2 restated filed Sept. 17, 2021
- Yu Fan 2021 Q2 filed Aug. 16, 2021
- Yu Fan 2020 Q4 amended filed May 17, 2021
- Yu Fan 2021 Q1 filed May 17, 2021
- Yu Fan 2020 Q4 filed Feb. 16, 2021